<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Khalfi P</submitter><funding>Ligue Contre le Cancer</funding><funding>Ministère de la Recherche</funding><funding>Institut Pasteur</funding><funding>Centre National de la Recherche Scientifique</funding><pagination>e1011170</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9983871</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>19(2)</volume><pubmed_abstract>Viruses have evolved countless mechanisms to subvert and impair the host innate immune response. Measles virus (MeV), an enveloped, non-segmented, negative-strand RNA virus, alters the interferon response through different mechanisms, yet no viral protein has been described as directly targeting mitochondria. Among the crucial mitochondrial enzymes, 5'-aminolevulinate synthase (ALAS) is an enzyme that catalyzes the first step in heme biosynthesis, generating 5'-aminolevulinate from glycine and succinyl-CoA. In this work, we demonstrate that MeV impairs the mitochondrial network through the V protein, which antagonizes the mitochondrial enzyme ALAS1 and sequesters it to the cytosol. This re-localization of ALAS1 leads to a decrease in mitochondrial volume and impairment of its metabolic pot</pubmed_abstract><journal>PLoS pathogens</journal><pubmed_title>Antagonism of ALAS1 by the Measles Virus V protein contributes to degradation of the mitochondrial network and promotes interferon response.</pubmed_title><pmcid>PMC9983871</pmcid><funding_grant_id>IP/SC-15364</funding_grant_id><pubmed_authors>Ghozlane A</pubmed_authors><pubmed_authors>Suspene R</pubmed_authors><pubmed_authors>Volant S</pubmed_authors><pubmed_authors>Tangy F</pubmed_authors><pubmed_authors>Vartanian JP</pubmed_authors><pubmed_authors>Rigaud S</pubmed_authors><pubmed_authors>Caval V</pubmed_authors><pubmed_authors>Caignard G</pubmed_authors><pubmed_authors>Khalfi P</pubmed_authors><pubmed_authors>Berry N</pubmed_authors><pubmed_authors>Rufie C</pubmed_authors><pubmed_authors>Raymond KA</pubmed_authors><pubmed_authors>Thiers V</pubmed_authors><pubmed_authors>Combredet C</pubmed_authors><pubmed_authors>Komarova AV</pubmed_authors></additional><is_claimable>false</is_claimable><name>Antagonism of ALAS1 by the Measles Virus V protein contributes to degradation of the mitochondrial network and promotes interferon response.</name><description>Viruses have evolved countless mechanisms to subvert and impair the host innate immune response. Measles virus (MeV), an enveloped, non-segmented, negative-strand RNA virus, alters the interferon response through different mechanisms, yet no viral protein has been described as directly targeting mitochondria. Among the crucial mitochondrial enzymes, 5'-aminolevulinate synthase (ALAS) is an enzyme that catalyzes the first step in heme biosynthesis, generating 5'-aminolevulinate from glycine and succinyl-CoA. In this work, we demonstrate that MeV impairs the mitochondrial network through the V protein, which antagonizes the mitochondrial enzyme ALAS1 and sequesters it to the cytosol. This re-localization of ALAS1 leads to a decrease in mitochondrial volume and impairment of its metabolic pot</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Feb</publication><modification>2026-07-15T01:38:12.417Z</modification><creation>2025-04-05T19:16:45.017Z</creation></dates><accession>S-EPMC9983871</accession><cross_references><pubmed>36802406</pubmed><doi>10.1371/journal.ppat.1011170</doi></cross_references></HashMap>